ArticleJournal of endocrinological investigation2012

Rosiglitazone attenuates tumor necrosis factor-α-induced protein-tyrosine phosphatase-1B production in HepG2 cells.

J Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.